Neutralizing anti-vascular endothelial growth factor antibody inhibits further growth of established prostate cancer and metastases in a pre- clinical model

Journal of Urology

Volumn 161, Issue 3, 1999, Pages 960-963

  Melnyk, Ostap ^a,b   Zimmerman, Michael ^a   Kim, K Jin ^a   Shuman, Marc ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Angiogenesis; DU 145; Metastasis; Prostate cancer; VEGF

Indexed keywords

ANGIOGENIC FACTOR; LUCIFERASE; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; DISEASE COURSE; EXPRESSION VECTOR; FEMALE; HUMAN; HUMAN CELL; LUNG METASTASIS; MALE; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; TUMOR GROWTH;

EID: 0032848409     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)61829-9     Document Type: Article

References (22)

1. Ferrara, N., Leung, D. W., Cachianes, G., Winer, J. and Henzel, W. J.: Purification and cloning of vascular endothelial growth factor secreted by pituitary folliculostellate cells. Methods Enzymol., 198: 391, 1991.
2. Collins, P. D., Connolly, D. T. and Williams, T. J.: Characterization of the increase in vascular permeability induced by vascular permeability factor in vivo. Br. J. Pharmacol., 109: 195, 1993.
3. Ferrara, N., Houck, K., Jakeman, L. and Leung, D. W.: Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocrine Rev., 13: 18, 1992.
4. Brown, L. F., Berse, B. and Jackman, R. W.: Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Hum. Pathol., 26: 86, 1995.
5. Warren, R. S., Yuan, H., Matli, M. R., Gillett, N. A. and Ferrara, N.: Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. J. Clin. Invest., 95: 1789, 1995.
6. Boocock, C. A., Charnock-Jones, D. S. and Sharkey, A. M.: Expression of vascular endothelial growth factor and its receptors fit and KDR in ovarian carcinoma. JNCI, 87: 506, 1995.
7. Berkman, R. A., Merrill, M. J. and Reinhold, W. C.: Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms. J. Clin. Invest., 91: 153, 1993.
8. Kim, J. K., Li, B. and Winer, J.: Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature, 362: 841, 1993.
9. Melnyk, O., Shuman, M. A. and Kim, K. J.: Vascular endothelial growth factor promotes tumor dissemination by a mechanism distinct from its effect on primary tumor growth. Cancer Res., 56: 921, 1996.
10. Weidner, N., Carroll, P. R., Flax, J., Blumenfeld, W. and Folkman, J.: Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am. J. Pathol., 143: 401, 1993.
11. Kim, K. J., Li, B., Houck, K., Winer, J. and Ferrara, N.: The vascular endothelial growth factor proteins: identification of biologically relevant regions by neutralizing monoclonal antibodies. Growth Factors, 7: 153, 1992.
12. Stone, K. R., Mickey, D. D., Wunderli, H., Mickey, G. H. and Paulson, D. F.: Isolation of a human prostate carcinoma cell line (DU 145). Int. J. Cancer, 21: 274, 1978.
13. Ferrara, N., Winer, J. and Burton, T.: Expression of vascular endothelial growth factor does not promote transformation but confers a growth advantage in vivo to Chinese hamster ovary cells. J. Clin. Invest., 91: 160, 1993.
14. Crowley, C. W., Cohen, R. L., Lucas, B. K., Liu, G., Shuman, M. A. and Levinson, A. D.: Prevention of metastasis by inhibition of the urokinase receptor. Proc. Natl. Acad. Sci. USA, 90: 5021, 1993.
15. Dvorak, H. F., Sioussat, T. M. and Brown, L. F.: Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels. J. Exp. Med., 174: 1275, 1991.
16. Millauer, B., Shawver, L. K., Plate, K. H., Risau, W. and Ullrich, A.: Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature, 367: 576, 1994.
17. Parangi, S., O'Reilly, M. and Christofori, G.: Antiangiogenic therapy of transgenic mice impairs de novo tumor growth. Proc. Natl. Acad. Sci. USA, 93: 2002, 1996.
18. O'Reilly, M. S., Boehm, T. and Shing, Y.: Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell, 88: 277, 1997.
19. Neeman, M., Abramovitch, R., Schiffenbauer, Y. S. and Tempel, C.: Regulation of angiogenesis by hypoxic stress: from solid tumours to the ovarian follicle. Int. J. Exp. Pathol., 78: 57, 1997.
20. Peters, K. G., De Vries, C. and Williams, L. T.: Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. Proc. Natl. Acad. Sci. USA, 90: 8915, 1993.
21. Garnick, M. B.: Prostate cancer: screening, diagnosis, and management [see comments] [published erratum appears in Ann. Int. Med., 120: 698, 1994]. Ann. Int. Med., 118: 804, 1993.
22. Garnick, M. B.: Prostate cancer: screening, diagnosis, and management [see comments] [published erratum appears in Ann. Int. Med., 120: 698, 1994]. Ann. Int. Med., 118: 804, 1993.